Sai Life Sciences’ IPO received a subscription rate of 10.27 times. The GMP of ₹58 suggests a listing price of ₹607.

Anteris Technologies, which is creating a new kind of transcatheter heart valve for aortic stenosis, aims to compete with ...

Rekha Jhunjhunwala-backed Inventurus Knowledge Solutions began for public subscription on December 12. The IPO will close for ...

The ASX is on track to end 2024 with fewer listed companies than it kicked the year off with, signalling a significant shift ...

U.S. president-elect Donald Trump, with SoftBank Group CEO Masayoshi Son at his side, announced on Monday that Tokyo-based ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Vishal Mega Mart's unlisted shares are trading in the grey market at Rs 97, reflecting a premium of Rs 19 or 24.36 per cent ...

The grey market continues to reflect strong sentiment, with MobiKwik's unlisted shares trading at Rs 444 per share, ...

Fast fashion retailer Shein is considering asking UK regulators to waive listing rules that require at least 10% of its ...

Klarna, which is expected to IPO next year, said in an internal memo that random drug testing is part of a broader effort to ...

Skims co-founder Jens Grede has confirmed that plans for an IPO are on the back burner — for now at least, according to a new interview with WWD.